This inventor holds 1 USPTO granted patent. Top assignee: Asahi Kasei Kogyo Kabushiki Kaisha. Active years: 1978.
Company Filing History:
Years Active: 1978
Title: Kunio Iitsuka: Innovator in Antiviral and Anticarcinogenic Drug Development
Introduction
Kunio Iitsuka is a notable inventor based in Fuji, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral and anticarcinogenic drugs. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Kunio Iitsuka holds a patent for a process titled "Process for preparing 8,2'-O-anhydropurine nucleosides." This process involves heating 2',3'-O-sulfinyl-8-oxypurine nucleosides in an aprotic polar solvent, in the presence of an alkali metal, alkaline earth metal, or ammonium salt of an inorganic or organic weak acid. This invention serves as an important intermediate for the development of antiviral and anticarcinogenic drugs, highlighting its potential impact on healthcare.
Career Highlights
Iitsuka is associated with Asahi Kasei Kogyo Kabushiki Kaisha, a prominent company in the chemical and pharmaceutical industry. His work at this organization has allowed him to collaborate with other talented professionals and contribute to groundbreaking research and development in the field.
Collaborations
Some of Kunio Iitsuka's coworkers include Kozo Tsunoda and Tsuneo Sowa. Their collaborative efforts have likely played a role in enhancing the innovative environment at Asahi Kasei Kogyo Kabushiki Kaisha.
Conclusion
Kunio Iitsuka's contributions to the field of pharmaceuticals through his patent for 8,2'-O-anhydropurine nucleosides exemplify his commitment to advancing medical science. His work not only showcases his inventive spirit but also holds promise for future developments in antiviral and anticarcinogenic therapies.